Physician profile
Kenneth J Baum
NPI 1871692269
$3,400.32
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $129 · 2021: $747 · 2022: $1,167 · 2023: $1,205 · 2024: $39.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,244.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $706.84 | 2022-2023 | |
| Abbvie INC. | $663.99 | 2022-2024 | Xen Glaucoma Treatment System |
| Alcon Vision LLC | $451.10 | 2021-2023 | Argos, Rocklatan |
| Dompe US, INC. | $245.00 | 2022-2023 | Oxervate |
| Allergan, INC. | $239.83 | 2020-2022 | |
| Aerie Pharmaceuticals, INC. | $171.86 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $160.99 | 2020-2021 | |
| Glaukos Corporation | $150.00 | 2021 | |
| Sight Sciences, INC. | $147.97 | 2022 | |
| Ivantis, INC | $127.87 | 2021 | |
| Rxsight INC | $119.56 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Sun Pharmaceutical Industries INC. | $78.24 | 2020-2023 | Cequa |
| Bausch & Lomb Americas INC. | $62.26 | 2022-2023 | Vyzulta, Prolensa |
| Amgen INC. | $20.27 | 2024 | Tepezza |
| Kala Pharmaceuticals, INC. | $19.39 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $18.78 | 2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $16.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Baum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.